Revumenib: a new potential targeted therapy for KMT2A-rearranged acute leukemia
@article{ACTR10518,
author = {Xavier Thomas},
title = {Revumenib: a new potential targeted therapy for KMT2A-rearranged acute leukemia},
journal = {AME Clinical Trials Review},
volume = {3},
number = {0},
year = {2025},
keywords = {},
abstract = {},
issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/10518}
}